Zhichen Sun

机构：The University of Texas Southwestern Medical Center · ORCID：0000-0001-7837-8407

发表论文 67 篇 · 总被引 2225 次 · h-index 20

代表论文

• STING licensing of type I dendritic cells potentiates antitumor immunity (2024 · Science Immunology · 被引 123)
• Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8+ T cells (2023 · Signal Transduction and Targeted Therapy · 被引 9)
• Membrane fusogenic nanoparticle‐based HLA ‐peptide‐addressing universal T cell receptor‐engineered T ( HAUL TCR‐T ) cell therapy in solid tumor (2023 · Bioengineering & Translational Medicine · 被引 8)
• STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)
• Dual targeting OX40 and IL-2 receptor enhances antitumor activity through tumor-infiltrating Treg depletion and CD8 + T-cell proliferation (2025 · Journal for ImmunoTherapy of Cancer · 被引 5)
• Stimuli-responsive STING nanovaccine for systemic therapy of HPV-induced cancers (2025 · Proceedings of the National Academy of Sciences · 被引 3)